S

SSY Group Ltd
HKEX:2005

Watchlist Manager
SSY Group Ltd
HKEX:2005
Watchlist
Price: 2.99 HKD Market Closed
Market Cap: 8.7B HKD

Relative Value

The Relative Value of one SSY Group Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 2.99 HKD, SSY Group Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SSY Group Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
63
vs Industry
60
Median 3Y
2
Median 5Y
2
Industry
2.6
Forward
1.8
vs History
31
vs Industry
42
Median 3Y
10.8
Median 5Y
12.5
Industry
21.6
Forward
12
vs History
11
vs Industry
32
Median 3Y
16.6
Median 5Y
17.7
Industry
16.5
vs History
15
vs Industry
12
Median 3Y
49.6
Median 5Y
32.3
Industry
22.5
vs History
90
vs Industry
52
Median 3Y
1.8
Median 5Y
1.8
Industry
2.3
vs History
26
vs Industry
56
Median 3Y
2.1
Median 5Y
2.1
Industry
2.9
Forward
2.2
vs History
6
vs Industry
59
Median 3Y
3.9
Median 5Y
3.9
Industry
5.5
vs History
17
vs Industry
42
Median 3Y
7.7
Median 5Y
8.2
Industry
13
Forward
8.3
vs History
25
vs Industry
44
Median 3Y
8.8
Median 5Y
9.8
Industry
16.6
Forward
11.7
vs History
6
vs Industry
30
Median 3Y
17.4
Median 5Y
18.7
Industry
15.8
vs History
vs Industry
5
Median 3Y
29.7
Median 5Y
39.6
Industry
19.1
vs History
90
vs Industry
56
Median 3Y
1.3
Median 5Y
1.3
Industry
1.9

Multiples Across Competitors

Competitors Multiples
SSY Group Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
HK
SSY Group Ltd
HKEX:2005
8.8B HKD 1.9 13.4 12.4 12.4
US
Eli Lilly and Co
NYSE:LLY
971.9B USD 16.4 52.8 35.5 38
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
509.1B USD 5.5 20.3 16.6 21.5
CH
Roche Holding AG
SIX:ROG
252.3B CHF 4.1 26.8 11.5 13.4
UK
AstraZeneca PLC
LSE:AZN
208.5B GBP 4.8 29.7 108.2 158.3
CH
Novartis AG
SIX:NOVN
202.4B CHF 4.5 17.7 11.2 14.5
US
Merck & Co Inc
NYSE:MRK
249.5B USD 3.9 13.1 9.3 11.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.5 13.7 9.6 11.2
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
147B USD 2.3 15 7.6 10.4
P/E Multiple
Earnings Growth PEG
HK
S
SSY Group Ltd
HKEX:2005
Average P/E: 22.5
13.4
-3%
N/A
US
Eli Lilly and Co
NYSE:LLY
52.8
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.3
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.8
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.7
38%
0.8
CH
Novartis AG
SIX:NOVN
17.7
17%
1
US
Merck & Co Inc
NYSE:MRK
13.1
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.7
4%
3.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
15
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
HK
S
SSY Group Ltd
HKEX:2005
Average EV/EBITDA: 399.9
12.4
-3%
N/A
US
Eli Lilly and Co
NYSE:LLY
35.5
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.6
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.2
10%
10.8
CH
Novartis AG
SIX:NOVN
11.2
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.3
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.6
2%
4.8
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
1%
7.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
HK
S
SSY Group Ltd
HKEX:2005
Average EV/EBIT: 1 711.2
12.4
-3%
N/A
US
Eli Lilly and Co
NYSE:LLY
38
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.5
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.3
23%
6.9
CH
Novartis AG
SIX:NOVN
14.5
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.1
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11.2
1%
11.2
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
8%
1.3